Literature DB >> 3265343

Influence of haemoglobin and erythrocytes on the effects of EDRF, a smooth muscle inhibitory factor, and nitric oxide on vascular and non-vascular smooth muscle.

J S Gillespie1, H Sheng.   

Abstract

1. The relaxant action of endothelium-derived relaxing factor (EDRF), the smooth muscle inhibitory factor (IF) isolated from the bovine retractor penis (BRP), nitric oxide (NO) and sodium nitroprusside (NaNP) on four vascular and non-vascular smooth muscle preparations has been examined. Their sensitivity to EDRF, the IF and NO was the same, suggesting all might be NO. Sodium nitroprusside produced complete relaxation of the rat anococcygeus at low doses, suggesting an action additional to the intracellular release of NO. 2. Haemoglobin added to solutions of EDRF, activated IF or NO completely removed their relaxant properties, consistent with all three acting by virtue of NO. 3. Suspensions of red blood cells with a haemoglobin concentration equivalent to to that used in the previous experiments were as effective as haemoglobin in abolishing the relaxant effect of EDRF or NO but were ineffective against the activated IF. 4. The similarity in sensitivity of a series of smooth muscles and the binding by haemoglobin are consistent with NO being the active principle of both EDRF and the acid activated IF. The abolition of the effect of EDRF by red blood cells (RBCs) is further confirmation for this hypothesis, but the ineffectiveness of RBCs against acid-activated IF suggests that either the latter is not NO or that it is bound in a way which makes it unable to diffuse through cell membranes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3265343      PMCID: PMC1854279          DOI: 10.1111/j.1476-5381.1988.tb11750.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  Extraction from ox retractor penis of an inhibitory substance which mimics its atropine-resistant neurogenic relaxation.

Authors:  N Ambache; S W Killick; M Aboo Aar
Journal:  Br J Pharmacol       Date:  1975-07       Impact factor: 8.739

2.  Differential selectivity of endothelium-derived relaxing factor and nitric oxide in smooth muscle.

Authors:  K Shikano; E H Ohlstein; B A Berkowitz
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

3.  A smooth muscle inhibitory material from the bovine retractor penis and rat anococcygeus muscles.

Authors:  J S Gillespie; W Martin
Journal:  J Physiol       Date:  1980-12       Impact factor: 5.182

4.  Some physical and chemical properties of the smooth muscle inhibitory factor in extracts of the bovine retractor penis muscle.

Authors:  J S Gillespie; J C Hunter; W Martin
Journal:  J Physiol       Date:  1981-06       Impact factor: 5.182

5.  The nature of endothelium-derived vascular relaxant factor.

Authors:  T M Griffith; D H Edwards; M J Lewis; A C Newby; A H Henderson
Journal:  Nature       Date:  1984 Apr 12-18       Impact factor: 49.962

6.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.

Authors:  R F Furchgott; J V Zawadzki
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

7.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

8.  The effect of ethanol on inhibitory and motor responses in the rat and rabbit anococcygeus and the bovine retractor penis muscles.

Authors:  J S Gillespie; J C Hunter; A T McKnight
Journal:  Br J Pharmacol       Date:  1982-01       Impact factor: 8.739

9.  Evidence that inhibitory factor extracted from bovine retractor penis is nitrite, whose acid-activated derivative is stabilized nitric oxide.

Authors:  W Martin; J A Smith; M J Lewis; A H Henderson
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

10.  Release and properties of endothelium-derived relaxing factor (EDRF) from endothelial cells in culture.

Authors:  T M Cocks; J A Angus; J H Campbell; G R Campbell
Journal:  J Cell Physiol       Date:  1985-06       Impact factor: 6.384

View more
  16 in total

Review 1.  NO and the vasculature: where does it come from and what does it do?

Authors:  Karen L Andrews; Chris R Triggle; Anthie Ellis
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

2.  Characterization and localization of nitric oxide synthase in non-adrenergic non-cholinergic nerves from bovine retractor penis muscles.

Authors:  H Sheng; H H Schmidt; M Nakane; J A Mitchell; J S Pollock; U Föstermann; F Murad
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

3.  On-line measurement of nitric oxide release from organic nitrates in the intact coronary circulation.

Authors:  K Schrör; S Förster; I Woditsch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-08       Impact factor: 3.000

4.  Modulation of cholinergic and substance P-like neurotransmission by nitric oxide in the guinea-pig ileum.

Authors:  C U Wiklund; C Olgart; N P Wiklund; L E Gustafsson
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

5.  Comparison of the effects of hydroxocobalamin and oxyhaemoglobin on responses to NO, EDRF and the nitrergic transmitter.

Authors:  M La; C G Li; M J Rand
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

6.  Comparison of relaxation responses of vascular and non-vascular smooth muscle to endothelium-derived relaxing factor (EDRF), acidified sodium nitrite (NO) and sodium nitroprusside.

Authors:  T M Cocks; J A Angus
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-04       Impact factor: 3.000

7.  A comparison of haemoglobin and erythrocytes as inhibitors of smooth muscle relaxation by the NANC transmitter in the BRP and rat anococcygeus and by EDRF in the rabbit aortic strip.

Authors:  J S Gillespie; H Sheng
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

8.  Mediators of nonadrenergic, noncholinergic inhibition in the proximal, middle and distal regions of rat colon.

Authors:  N Suthamnatpong; F Hata; A Kanada; T Takeuchi; O Yagasaki
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

9.  Nitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathways.

Authors:  F Fabi; R Calabrese; T Stati; P del Basso
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

10.  Cardiovascular actions of the furoxan CAS 1609, a novel nitric oxide donor.

Authors:  H Bohn; J Brendel; P A Martorana; K Schönafinger
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.